20th Annual Scientific Symposium Of The Cardiovascular Research Foundation: Oct. 12-17 In Washington, D.C.
Main Category: Cardiovascular / CardiologyAlso Included In: Conferences; Medical Devices / Diagnostics; Clinical Trials / Drug Trials
Article Date: 21 Sep 2008 - 11:00 PDT
Scientists at TCT 2008 - Transcatheter Cardiovascular Therapeutics - the global annual scientific symposium of the Cardiovascular Research Foundation - will present a variety of new data that promises to advance the field of interventional cardiology. Featured trials will focus on the safety and efficacy of new devices, including drug-eluting stents and other leading edge technologies, as well as comparisons of minimally invasive therapies to either medical treatment or surgery.
The following late breaking trials will be reported:
- HORIZONS-AMI: A Prospective Randomized Trial of Paclitaxel-Eluting Stents vs. Bare-Metal Stents in Patients with Acute ST-Segment Elevation Myocardial Infarction
- HORIZONS-AMI: A Prospective Randomized Trial of Bivalirudin vs. Unfractionated Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Acute ST-Segment Elevation Myocardial Infarction: Long-Term Follow-Up and Interaction with Stent Type
- SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease
- ISAR-Left Main: A Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents in Unprotected Left Main Coronary Artery Disease
- FAME: A Prospective Randomized Trial of Fractional Flow Reserve Guided Stenting in Patients with Multivessel Coronary Artery Disease
- ZEST-AMI: A Prospective Randomized Comparison of Zotarolimus-Eluting Stents, Sirolimus-Eluting Stents, and Paclitaxel-Eluting Stents in Patients with Acute Myocardial Infarction
- PREPARE: A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- BBC ONE: A Prospective Randomized Comparison of a Single Drug-Eluting Stent Provisional Strategy vs. Routine Dual Drug-Eluting Stents for Coronary Bifurcation Lesions
- ISAR-TEST-2: A Prospective Randomized Trial Comparing Polymer-Free Rapamycin-Eluting and Probucol-Eluting Stents, Polymer-Based Sirolimus-Eluting Stents, and Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease
In addition, research presented at TCT will showcase breaking data in other areas of interventional cardiology:
- Drug therapies that may reduce plaque
- The differences in the ways that men and women with similar symptoms are treated by physicians
- New types of stents, including bioabsorbable devices
- New ways of detecting and reducing plaque, including vulnerable plaque that can cause sudden heart attack and death
October 12-17, 2008; Late-breaking clinical trials will be highlighted during press conferences scheduled on Tuesday, October 14, Wednesday, October 15, and Thursday, October 16.
WHERE:
Walter E. Washington Convention Center; Washington, DC
----------------------------
Article adapted by Medical News Today from original press release.
----------------------------
Source: Judy Romero
Cardiovascular Research Foundation
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2009 MediLexicon International Ltd |



